Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has announcements × Lenalidomide × 30 days × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Large B-Cell, Diffuse 1

Interventions

pembrolizumab 10 Gemcitabine 7 Cisplatin 7 Carboplatin 7 Pemetrexed 4 Paclitaxel 4 Ipilimumab 4 durvalumab 3 Rituximab 3 Nivolumab 3 Cyclophosphamide 3 Brentuximab Vedotin 3 zanubrutinib 2 talquetamab 2 obinutuzumab 2 niraparib 2 lenvatinib 2 inavolisib 2 entrectinib 2 atezolizumab 2 X-Rays 2 Vincristine 2 Specimen Handling 2 Saline Solution 2 Prednisone 2 Leucovorin 2 Fluorouracil 2 Etoposide 2 Bendamustine Hydrochloride 2 Albumin-Bound Paclitaxel 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04404283 2026-03-17

ECHELON-3

Seagen Inc.

Phase 3 Active not recruiting

238 enrolled 1 FDA

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡